Real Estate Healthcare Sector

Atai Life Sciences

Market Cap: US$329.7m

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada.

American Oncology Network

Market Cap: US$328.5m

Through its subsidiaries, provides oncology management services in the United States.

Varex Imaging

Market Cap: US$327.1m

Designs, manufactures, and sells X-ray imaging components.

XOMA Royalty

Market Cap: US$323.0m

Operates as a biotech royalty aggregator in the United States and the Asia Pacific.

Olema Pharmaceuticals

Market Cap: US$322.3m

A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women’s cancers.

National Research

Market Cap: US$319.9m

Provides analytics and insights that facilitate measurement and improvement of the patient and employee experience.

CytomX Therapeutics

Market Cap: US$319.8m

Operates as an oncology-focused biopharmaceutical company that focuses on developing novel conditionally activated biologics localized to the tumor microenvironment.

Arcturus Therapeutics Holdings

Market Cap: US$316.0m

Engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases.

Pacific Biosciences of California

Market Cap: US$310.6m

Designs, develops, and manufactures sequencing solution to resolve genetically complex problems.

Alumis

Market Cap: US$305.8m

A clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders.

Cresco Labs

Market Cap: CA$426.5m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States.

Heron Therapeutics

Market Cap: US$300.6m

A commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care.

Aura Biosciences

Market Cap: US$299.1m

A clinical-stage biotechnology company, develops precision immunotherapies to treat a range of solid tumors.

iTeos Therapeutics

Market Cap: US$298.9m

A clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients with cancer.

Abeona Therapeutics

Market Cap: US$296.1m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

aTyr Pharma

Market Cap: US$291.0m

A clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States.

Compass Therapeutics

Market Cap: US$290.4m

A clinical-stage oncology-focused biopharmaceutical company, engages in the development of antibody-based therapeutics for the treatment of various human diseases in the United States.

Immutep

Market Cap: AU$445.4m

A late-stage biotechnology company, engages in developing novel LAG-3 related immunotherapies for cancer and autoimmune diseases in Australia.

Entrada Therapeutics

Market Cap: US$285.2m

A clinical-stage biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases.

Phathom Pharmaceuticals

Market Cap: US$284.5m

A biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases.

Health Catalyst

Market Cap: US$282.6m

Provides data and analytics technology and services to healthcare organizations in the United States.

Aurora Cannabis

Market Cap: CA$393.0m

Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

EBR Systems

Market Cap: AU$436.2m

Develops implantable systems for wireless tissue stimulation.

Sanara MedTech

Market Cap: US$280.0m

A medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States.

Oceania Healthcare

Market Cap: NZ$470.8m

Owns and operates various care centers and retirement villages in New Zealand.

Neuronetics

Market Cap: US$277.8m

Engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally.

Healwell AI

Market Cap: CA$387.1m

A healthcare artificial intelligence company, develops and commercializes clinical decision support systems in Canada, New Zealand, Australia, and the United Kingdom.

SANUWAVE Health

Market Cap: US$276.2m

Operates as a medical device company in the United States and internationally.

Panamera Holdings

Market Cap: US$273.1m

Does not have significant operations.

Imricor Medical Systems

Market Cap: AU$423.1m

A medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East.

Quantum-Si

Market Cap: US$271.6m

A life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS).

Candel Therapeutics

Market Cap: US$268.0m

A clinical stage biopharmaceutical company, develops immunotherapies for the cancer patients.

Viemed Healthcare

Market Cap: US$267.2m

Through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States.

Cartesian Therapeutics

Market Cap: US$266.3m

A clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases.

Canopy Growth

Market Cap: CA$362.2m

Engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally.

Neurogene

Market Cap: US$256.6m

A clinical stage biotechnology company, develops genetic medicines for rare neurological diseases.